New patent for Strongbridge drug RECORLEV

   April 14, 2024    Comments Off on New patent for Strongbridge drug RECORLEV    Posted in: Patent Added

Annual Drug Patent Expirations for RECORLEV Recorlev is a drug marketed by Strongbridge and is included in one NDA. It is available from one supplier. There are seven patents protecting…
Source

Continue reading

New patent for Glaxo Grp drug ADVAIR HFA

   April 14, 2024    Comments Off on New patent for Glaxo Grp drug ADVAIR HFA    Posted in: Patent Added

Annual Drug Patent Expirations for ADVAIR+HFA Advair Hfa is a drug marketed by Glaxo Grp Ltd and is included in one NDA. It is available from three suppliers. There is…
Source

Continue reading
Biotechblog